Breaking News
Latest Blogs
Table of Contents
Volume 34, Issue 1 (April 15, 2025)
Article
Tariffs Heighten Uncertainty for Instrument Firms
Executive Briefing
The latest on QIAGEN, Bruker and more
Financial
Fourth Quarter Results: 10x Genomics, HORIBA, Oxford Nanopore, QIAGEN and Tecan
Market Profile
Spectral Flow Cytometry
Industry Watch
Government and R&D
Clinical
Government and Biopharma
Region Watch
UK
China
EU
News
Broad-Based Companies
Life Science Instruments
Gene-Based Analysis
Cell-Based Analysis
Protein-Based Analysis
Chromatography
Bioprocess Analysis
Bottom Line
Companies’ latest financial results
Federal R&D Obligations for the NIH Decline in FY24
The recent plan by the Trump Administration to cap indirect costs for NIH academic research, which has been put on hold by a federal judge, as well as cuts to several other agencies that are major funders of R&D, has put the spotlight on federal R&D spending. This month, the National Science Foundation’s (NSF’s) National […]
Paving The Way for Change: 10x Genomics Announces Corporate Strategies for a Fruitful 2025
10x Genomics (10x) is a US-based life science technology company that manufactures genomic and cell analysis technology for scientific research applications. Specifically, the firm’s products and offerings cater to end-users conducting bulk, single-cell and spatial biology analyses. Due to being part of the research scientific tools market, 10x’s co-founder and CEO Serge Saxonov, Ph.D., presented […]
SLAS2025: Lab Automation and More
The SLAS2025 International Conference and Exhibition, one of the annual conferences of the Society for Laboratory Automation and Screening (SLAS), will be held at the San Diego Convention Center in San Diego, California, from January 25 to 29. SLAS is a professional society whose members include researchers as well as developers and providers of lab […]
LAUDA: Temperature Control Innovation
Founded in Germany in 1956, family-owned LAUDA DR. R. WOBSER GMBH & CO. KG (LAUDA) has become one of the most well-known companies for laboratory temperature-control equipment. Today, the company boasts $120 million in annual sales and a workforce of 600. End-markets served include the pharma/biotech (32% of sales), automotive (20%), chemical (20%), medicine (10%) […]
Perseverance Forecasted for the Pharmaceutical Market for Analytical and Scientific Instrumentation
The advent of the COVID-19 pandemic in 2020 highlighted the importance of the pharmaceutical and biopharmaceutical sectors as scientists worked tirelessly utilizing analytical and scientific instruments to create vaccines to combat the virus. Now that the pandemic has subsided, both the pharma and biotech markets are struggling with issues such as lack of funding for […]